1,500,000,000 9.250% SENIOR NOTES DUE 2026Valeant Pharmaceuticals International, Inc. • March 27th, 2018 • Pharmaceutical preparations • New York
THIS INDENTURE dated as of March 26, 2018 is among Valeant Pharmaceuticals International, a corporation duly organized under the laws of the State of Delaware (the “Company”), Valeant Pharmaceuticals International, Inc., a corporation continued under the British Columbia Business Corporations Act (the “Parent”), the other Note Guarantors party hereto and The Bank of New York Mellon (“BNY Mellon”), a New York banking corporation, not in its individual capacity but solely as Trustee, Registrar, and Paying Agent (the “Trustee”).
